I read this board regularly. I was lucky enough to get in years ago then get out. Then this year I got back in when I saw signs of life.
IMO, you are all right. The cheerleaders have good points and good reasons to be excited and the critics do as well.
For the critics, I think that it is really hard to judge the leadership as a failure. The stem cell market is unchartered territory and there have surely been mistakes along the way. However, they are pioneers and there isn't any textbook on how to stand up a game changing company in unknown territory. In brief summary, the valid criticisms that I find undisputed come down to 2 things. CEO bonuses-totally agreed. And lack of transparency around failures and schedule misses. Failures are acceptable but non disclosure direct distrust and justified criticism.
For the cheerleaders. Great technology, product, and I agree on the doorstep of advancement. Don't be so celebratory and naive around management though. Zami was an excellent visionary and strategist to go after the 3D technology and placental source, but the naysayers do have some good points about bringing in industry experience and more business horse power. Management does matter! Look at GE. Trainwrecks everwhere with cost and cash flow front and center.
Finally. I outlined a strategy early on here on this board that drew lots of criticism from the cheerleaders. Panic selling and bailing is always stupid but I decided to sell half to mitigate risks around the uncertainty in
Management and kept half because of my faith in the product. Admittedly, I added back 1/3 to my position back around $1.40 and I'm good to go now. The milestones are in sight but I left off a couple thousands shares in case of a setback. If management would just tell us what's happening, I'd go all in on the good, bad and ugly.
Good luck to all of you and I do hope for imminent management and product
Sucess.
News 
Market Data 
Discover 
